Overview

Neurological conditions are among the leading causes of disability worldwide, with incidence expected to rise significantly as populations age. The Bioelectronic Neuromodulation Innovation To Cure Program addresses this urgent need by connecting discovery science, engineering innovation and clinical application to advance earlier disease detection, personalized neuromodulation and regenerative therapies that move beyond symptom management toward durable solutions.

The program focuses on transforming the diagnosis, treatment and prevention of neurological disease. Clinicians, scientists, engineers and data experts work together to create integrated solutions that span discovery, validation and clinical implementation. The program's approach is grounded in Mayo Clinic's patient-centered model, combining multidisciplinary expertise with advanced infrastructure to deliver meaningful clinical impact.

The program integrates neurotechnology, biologics, artificial intelligence (AI) and clinical translation to accelerate the development of next-generation therapies that preserve and restore brain and nervous system function. The program delivers scalable, patient-centered solutions across neurological conditions, including epilepsy, Parkinson's disease, neurodegeneration, brain tumors, spinal cord injury and psychiatric disorders.

Focus areas

Core focus areas include:

• Neurotechnology and device innovation. The program develops implantable and wearable systems for sensing, stimulation and closed-loop neuromodulation.
• Biologics and regenerative therapeutics. Cellular and molecular approaches restore neural circuits and modulate disease processes.
• Clinical translation and application. The program integrates advanced therapies into clinical trials and real-world care delivery models.
• Data science, AI and digital platforms. The program uses multimodal data integration, predictive modeling and real-time therapeutic optimization.

Strategic vision

The Bioelectronic Neuromodulation Innovation To Cure Program aims to enable:

• Early detection of neurological disease through predictive biomarkers.
• Personalized therapies tailored to individual neurophysiology.
• Continuous monitoring and adaptive treatment through integrated devices and platforms.
• Regeneration and restoration of neural function across the lifespan.

By combining Mayo Clinic's clinical scale, scientific expertise and digital infrastructure, the program is positioned to lead the next era of neuroscience innovation.